Pacific Biosciences of California, Inc.PACBNASDAQ
Loading
Year-over-year revenue growth rate
5Y CAGR
-17.5%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 16.14% |
| Q3 2025 | -3.33% |
| Q2 2025 | 7.03% |
| Q1 2025 | -5.28% |
| Q4 2024 | -1.86% |
| Q3 2024 | 10.98% |
| Q2 2024 | -7.21% |
| Q1 2024 | -33.50% |
| Q4 2023 | 4.79% |
| Q3 2023 | 17.06% |
| Q2 2023 | 22.30% |
| Q1 2023 | 42.21% |
| Q4 2022 | -15.34% |
| Q3 2022 | -8.90% |
| Q2 2022 | 6.92% |
| Q1 2022 | -7.90% |
| Q4 2021 | 3.24% |
| Q3 2021 | 13.97% |
| Q2 2021 | 5.56% |
| Q1 2021 | 6.86% |
| Q4 2020 | 42.21% |
| Q3 2020 | 11.74% |
| Q2 2020 | 9.48% |
| Q1 2020 | -44.15% |
| Q4 2019 | 27.45% |
| Q3 2019 | -10.99% |
| Q2 2019 | 49.90% |
| Q1 2019 | -15.88% |
| Q4 2018 | 7.52% |
| Q3 2018 | -15.84% |
| Q2 2018 | 11.45% |
| Q1 2018 | -22.35% |
| Q4 2017 | 5.90% |
| Q3 2017 | 17.30% |
| Q2 2017 | -19.43% |
| Q1 2017 | -3.14% |
| Q4 2016 | 2.40% |
| Q3 2016 | 21.07% |
| Q2 2016 | 8.47% |
| Q1 2016 | -47.28% |